Clinical trial

Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial

NCT06661902

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Lidocaine Normalized identity: lidocaineView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Biopsy of Prostate Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Questionnaire Administration Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-01-09

PhasePHASE1 / PHASE2

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Buffered Lidocaine (1% Lidocaine + 8.4% Sodium Bicarbonate, in a 3:1 ratio)DRUG

LidocaineDRUG · verified · RxNorm: lidocaine

Biopsy of ProstatePROCEDURE

Questionnaire AdministrationOTHER

Sponsors & collaborators

University of Washingtonlead sponsor

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06661902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.